Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Basilea Pharmaceutica Ltd.

Headquarters: Basel, Switzerland
Year Founded: 2000
Status: Public
Industry Sector: HealthTechnology
CEO: David Veitch
Number Of Employees: 164
Enterprise Value: $620,586,108
PE Ratio: 6.27
Exchange/Ticker 1: SIX:BSLN
Exchange/Ticker 2: N/A
Latest Market Cap: $569,422,995

BioCentury | Jun 29, 2024
Data Byte

Regeneron’s CD20xCD3 therapy among new recommendations by EMA’s CHMP

Plus: Regulatory body has positive opinion on Winrevair, negative opinions on Syfovre and Translarna 
BioCentury | Jan 23, 2024
Deals

Deals roundup: Coherus sharpens oncology focus, BridgeBio bolsters balance sheet and more

BioCentury’s weekly roundup of biopharma deals, Jan. 16-22
BioCentury | Nov 14, 2023
Finance

Nov. 13 Quick Takes: Legend finds next CAR partner in Novartis

Plus: EQT, Forbion lead €129M A round for VectorY and updates from ViaNautis Bio, Cartesian, Aclaris, Anthos, Basilea, and Blueberry 
BioCentury | Oct 13, 2022
Management Tracks

Maag becomes CEO at Kyverna

Plus Bernstein to head R&D at Maze, and updates from Visiox, Araris, Quest and Biohaven
BioCentury | Apr 20, 2018
Company News

Basilea gains rights to ArQule's derazantinib

BioCentury | Apr 17, 2018
Company News

Basilea gains rights to ArQule's derazantinib

Items per page:
1 - 10 of 34
Help Center
Username
Request a Demo
Request Training
Ask a Question